Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2014-07-10 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BASSENS (73000), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DU PRADIAN : revenue, balance sheet and financial ratios
SELAS PHARMACIE DU PRADIAN is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BASSENS (73000),
this company of category PME
shows in 2025 a net income positive of 295 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DU PRADIAN (SIREN 803535863)
Indicator
2025
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
294 547 €
268 940 €
282 059 €
392 931 €
269 091 €
321 021 €
300 726 €
230 712 €
220 078 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE DU PRADIAN generates positive net income of 295 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 220 k€ -> 295 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
294 547 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 691%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
691.189%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
10.773%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DU PRADIAN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Debt ratio
565.877
387.21
265.117
185.079
156.665
77.676
60.105
1127.059
691.189
Financial autonomy
13.328
18.306
24.455
30.85
34.897
50.284
55.504
6.854
10.773
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
691.192025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch+29 pts over 3 years
In 2025, the debt ratio of SELAS PHARMACIE DU PRADIAN (691.19) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
10.77%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch-34 pts over 3 years
In 2025, the financial autonomy of SELAS PHARMACIE DU PRADIAN (10.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 153.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
153.376
Liquidity indicators evolution SELAS PHARMACIE DU PRADIAN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Liquidity ratio
129.497
131.063
143.176
126.988
166.155
144.606
133.499
109.267
153.376
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
153.382025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average+11 pts over 3 years
In 2025, the liquidity ratio of SELAS PHARMACIE DU PRADIAN (153.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELAS PHARMACIE DU PRADIAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELAS PHARMACIE DU PRADIAN is estimated at
4 678 914 €
(range 3 175 133€ - 7 341 860€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3175k€4678k€7341k€
4 678 914 €Range: 3 175 133€ - 7 341 860€
NAF 5 année 2025
Valuation method used
Net Income Multiple
294 547 €
×
15.9x
=4 678 914 €
Range: 3 175 133€ - 7 341 861€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DU PRADIAN with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DU PRADIAN
What is the revenue of SELAS PHARMACIE DU PRADIAN ?
The revenue of SELAS PHARMACIE DU PRADIAN is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DU PRADIAN profitable?
Yes, SELAS PHARMACIE DU PRADIAN generated a net profit of 295 k€ in 2025.
Where is the headquarters of SELAS PHARMACIE DU PRADIAN ?
The headquarters of SELAS PHARMACIE DU PRADIAN is located in BASSENS (73000), in the department Savoie.
Where to find the tax return of SELAS PHARMACIE DU PRADIAN ?
The tax return of SELAS PHARMACIE DU PRADIAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DU PRADIAN operate?
SELAS PHARMACIE DU PRADIAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart